Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational Studies toward the Identification of CB2R-M1R Dual Modulators.

ACS omega·2026
Same author

Structural and functional dissection of the WH2/DAD motif of INF2, a formin linked to human inherited degenerative disorders.

The FEBS journal·2025
Same author

Inherited retinal diseases in Kentucky: diagnostic yield, gene variants, and novel mutations in a U.S. population.

BMC medical genomics·2025
Same author

Targeting APC/C Ubiquitin E3-Ligase Activation with Pyrimidinethylcarbamate Apcin Analogues for the Treatment of Breast Cancer.

Biomolecules·2024
Same author

Progress on the development of Class A GPCR-biased ligands.

British journal of pharmacology·2024
Same author

Homodimerization of CB<sub>2</sub> cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.

Pharmacological research·2024
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K

CBD: A New Hope?

Paula Morales1, Patricia H Reggio2

  • 1Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid 28006, Spain.

ACS Medicinal Chemistry Letters
|May 18, 2019
PubMed
Summary
This summary is machine-generated.

The Food and Drug Administration approved cannabidiol (CBD) for treating drug-resistant epilepsy in children. This breakthrough advances cannabinoid research, exploring CBD

More Related Videos

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
07:36

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

2.3K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

3.7K

Related Experiment Videos

Last Updated: Jan 24, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K
Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
07:36

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

2.3K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

3.7K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Cannabidiol (CBD), a nonpsychoactive phytocannabinoid, has gained significant attention following its FDA approval for treating specific forms of epilepsy.
  • This regulatory milestone underscores the growing therapeutic potential of cannabinoids in medicine.

Discussion:

  • The mechanism of action for CBD is complex and involves multiple molecular targets.
  • Research is actively exploring how CBD interacts with the endocannabinoid system and other signaling pathways.

Key Insights:

  • Recent advancements provide molecular insights into how CBD exerts its therapeutic effects.
  • The efficacy of CBD in drug-resistant epilepsy highlights its potential for other neurological conditions.

Outlook:

  • Further research into CBD's pharmacology and clinical applications is warranted.
  • The approval of CBD paves the way for broader investigation into the therapeutic uses of phytocannabinoids.